A new treatment option for children with type 2 diabetes |
Editorial
eMediNexus Coverage from: 
A new treatment option for children with type 2 diabetes
Dr Sanjay Kalra, DM, Bharti Hospital, Karnal Immediate Past President, Endocrine Society of India,  27 July 2021
Coronavirus Live Count Map India

remove_red_eye 1630 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

1 Read Comments                

Exenatide extended release  has now been accorded US FDA approval for use in children aged ≥10 years with type 2 diabetes in addition to diet and exercise to improve glycemic control. This makes it the second glucagon-like peptide-1 receptor agonist approved for use in pediatric type 2 diabetes, after liraglutide, which was approved in 2019.This injectable formulation is not recommended as a first treatment option for patients whose disease is not adequately controlled through diet and e...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now